Mitochondrial dysfunction in human pathologies

Frontiers in Bioscience

Volumn 12, Issue 3, 2007, Pages 1131-1153

  Monsalve, María ^a,b,c   Borniquel, Sara ^a,b,c   Valle, Inmaculada ^a,b,c   Lamas, Santiago ^a,b,c  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^c Instituto Reina Sofia de Investigacion Nefrologica   (Spain)

Author keywords

Aging; Alzhemer disease; Atheroesclerosis; Cancer; Diabetes; Epilepsy; Huntington disease; Neurological diseases; Parkinson disease; Review

Indexed keywords

EID: 34249819676     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2132     Document Type: Article

References (269)

1. Brand M D, C. Affourtit, T. C. Esteves, K. Green, A. J. Lambert, S. Miwa, J. L. Pakay & N. Parker: Mitochondrial Superoxide: production, biological effects, and activation of uncoupling proteins. Free Radic Biol Med 37, 755-767 (2004)
2. Scarpulla R C: Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim Biophys Acta 1576, 1-14 (2002)
3. Duchen M R: Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol Aspects Med 25, 365-451 (2004)
4. Wallace D C: Mitochondrial diseases in man and mouse. Science 283, 1482-1488 (1999)
5. Finsterer J: Mitochondriopathies. Eur J Neurol 11, 163-186 (2004)
6. Nordberg J & E. S. Arner: Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radie Biol Med 31, 1287-1312 (2001)
7. Li Y, T. T. Huang, E. J. Carlson, S. Melov, P. C. Ursell, J. L. Olson, L. J. Noble, M. P. Yoshimura, C. Berger, P. H. Chan, D. C. Wallace & C. J. Epstein: Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11, 376-381 (1995)
8. Chen Z, B. Siu, Y. S. Ho, R. Vincent, C. C. Chua, R. C. Hamdy & B. H. Chua: Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J Mol Cell Cardiol 30, 2281-2289 (1998)
9. Chen H, X. Li & P. N. Epstein MnSOD and catalase transgenes demonstrate that protection of islets from oxidative stress does not alter cytokine toxicity. Diabetes 54, 1437-1446 (2005)
10. Callio J, T. D. Oury & C. T. Chu: Manganese superoxide dismutase protects against 6-hydroxydopamine injury in mouse brains. J Biol Chem 280, 18536-18542 (2005)
11. Ho Y S, R. Vincent, M. S. Dey, J. W. Slot & J. D. Crapo: Transgenic models for the study of lung antioxidant defense: enhanced manganese-containing Superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia. Am J Respir Cell Mol Biol 18, 538-547 (1998)
12. Goth L, P. Rass & A. Pay: Catalase enzyme mutations and their association with diseases. Mol Diagn 8, 141-149 (2004)
13. Ho Y S, Y. Xiong, W. Ma, A. Spector & D. S. Ho: Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J Biol Chem 279, 32804-32812 (2004)
14. Ho Y S, J. L. Magnenat, M. Gargano & J. Cao: The nature of antioxidant defense mechanisms: a lesson from transgenic studies. Environ Health Perspect 106 Suppl 5, 1219-1228 (1998)
15. Yang H, L. J. Roberts, M. J. Shi, L. C. Zhou, B. R. Ballard, A. Richardson & Z. M. Guo: Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein. E Circ Res 95, 1075-1081 (2004)
16. Shi M, H. Yang, E. D. Motley & Z. Guo: Overexpression of Cu/Zn-superoxide dismutase and/or catalase in mice inhibits aorta smooth muscle cell proliferation. Am J Hypertens 17, 450-456 (2004)
17. Schriner S E, N. J. Linford, G. M. Martin, P. Treuting, C. E. Ogburn, M. Emond, P. E. Coskun, W. Ladiges, N. Wolf, H. Van Remmen, D. C. Wallace & P. S. Rabinovitch: Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308, 1909-1911 (2005)
18. Watabe S, T. Hiroi, Y. Yamamoto, Y. Fujioka, H. Hasegawa, N. Yago & S. Y. Takahashi: SP-22 is a thioredoxin-dependent peroxide reductase in mitochondria. Eur J Biochem 249, 52-60 (1997)
19. Araki M, H. Nanri, K. Ejima, Y. Murasato, T. Fujiwara, Y. Nakashima & M. Ikeda: Antioxidant function of the mitochondrial protein SP-22 in the cardiovascular system. J Biol Chem 274, 2271-2278 (1999)
20. Seo M S, S. W. Rang, K. Kim, I. C. Baines, T. H. Lee & S. G. Rhee: Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J Biol Chem 275, 20346-20354 (2000)
21. Zhou Y, K. H. Kok, A. C. Chun, C. M. Wong, H. W. Wu, M. C. Lin, P. C. Fung, H. Kung & D. Y. Jin: Mouse peroxiredoxin V is a thioredoxin peroxidase that inhibits p53-induced apoptosis. Biochem Biophys Res Commun 268, 921-927 (2000)
22. Banmeyer I, C. Marchand, A. Clippe & B. Knoops: Human mitochondrial peroxiredoxin 5 protects from mitochondrial DNA damages induced by hydrogen peroxide. FEBS Lett 579, 2327-2333 (2005)
23. Banmeyer I, C. Marchand, C. Verhaeghe, B. Vucic, J. F. Rees & B. Knoops: Overexpression of human peroxiredoxin 5 in subcellular compartments of Chinese hamster ovary cells: effects on cytotoxicity and DNA damage caused by peroxides. Free Radic Biol Med 36, 65-77 (2004)
24. Tien Nguyen-nhu N & B. Knoops: Mitochondrial and cytosolic expression of human peroxiredoxin 5 in Saccharomyces cerevisiae protect yeast cells from oxidative stress induced by paraquat. FEBS Lett 544, 148-152 (2003)
25. Kinnula V L, S. Lehtonen, R. Sormunen, R. Kaarteenaho-Wiik, S. W. Kang, S. G. Rhee & Y. Soini: Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma. J Parthol 196, 316-323 (2002)
26. Choi J H, T. N. Kim, S. Kim, S. H. Back, J. H. Kim, S. R. Lee & J. R. Kim: Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas. Anticancer Res 22, 3331-3335 (2002)
27. Noh D Y, S. J. Ahn, R. A. Lee, S. W. Kim, I. A. Park & H. Z. Chae Overexpression of peroxiredoxin in human breast cancer. Anticancer Res 21, 2085-2090 (2001)
28. Karihtala P, A. Mantyniemi, S. W. Kang, V. L. Kinnula & Y. Soini: Peroxiredoxins in breast carcinoma. Clin Cancer Res 9, 3418-3424 (2003)
29. Chang T S, C. S. Cho, S. Park, S. Yu, S. W. Kang & S. G. Rhee: Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria. J Biol Chem 279, 41975-41984 (2004)
30. Nonn L, M. Berggren & G. Powis: Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis. Mol Cancer Res 1, 682-689 (2003)
31. Chandel N S, E. Maltepe, E. Goldwasser, C. E. Mathieu, M. C. Simon & P. T. Schumacker Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 95, 11715-11720 (1998)
32. Chae H Z, S. W. Kang & S. G. Rhee: Isoforms of mammalian peroxiredoxin that reduce peroxides in presence of thioredoxin. Methods Enzymol 300, 219-226 (1999)
33. Miranda-Vizuete A, A. E. Damdimopoulos, J. R. Pedrajas, J. A. Gustafsson & G. Spyrou: Human mitochondrial thioredoxin reductase cDNA cloning, expression and genomic organization. Eur J Biochem 261, 405-412 (1999)
34. Spyrou G, E. Enmark, A. Miranda-Vizuete & J. Gustafsson: Cloning and expression of a novel mammalian thioredoxin. J Biol Chem 272, 2936-2941 (1997)
35. Miranda-Vizuete A, A. E. Damdimopoulos & G. Spyrou: The mitochondrial thioredoxin system. Antioxid Redox Signal 2, 801-810 (2000)
36. Damdimopoulos A E, A. Miranda-Vizuete, M. PeltoHuikko, J. A. Gustafsson & G. Spyrou: Human mitochondrial thioredoxin. Involvement in mitochondrial membrane potential and cell death. J Biol Chem 277, 33249-33257 (2002)
37. Chen Y, J. Cai, T. J. Murphy & D. P. Jones: Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells. J Biol Chem 277, 33242-33248 (2002)
38. Nonn L, R. R. Williams, R. P. Erickson & G. Powis: The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol Cell Biol 23, 916-922 (2003)
39. Tanaka T, F. Hosoi, Y. Yamaguchi-Iwai, H. Nakamura, H. Masutani, S. Ueda, A. Nishiyama, S. Takeda, H. Wada, G. Spyrou & J. Yodoi: Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. Embo J 21, 1695-1703 (2002)
40. Chiueh C C, T. Andoh & P. B. Chock: Induction of thioredoxin and mitochondrial survival proteins mediates preconditioning-induced cardioprotection and neuroprotection. Ann N Y Acad Sci 1042, 403-418 (2005)
41. Stroev S A, T. S. Gluschenko, E. I. Tjulkova, G. Spyrou, E. A. Rybnikova, M. O. Samoilov & M. Pelto-Huikko: Preconditioning enhances the expression of mitochondrial antioxidant thioredoxin-2 in the forebrain of rats exposed to severe hypobaric hypoxia. J Neurosci Res 78, 563-569 (2004)
42. Rabilloud T, M. Heller, M. P. Rigobello, A. Bindoli, R. Aebersold & J. Lunardi: The mitochondrial antioxidant defence system and its response to oxidative stress. Proteomics 1, 1105-1110 (2001)
43. Lee S R, J. R. Kim, K. S. Kwon, H. W. Yoon, R. L. Levine, A. Ginsburg & S. G. Rhee: Molecular cloning and characterization of a mitochondrial selenocysteine-containing thioredoxin reductase from rat liver. J Biol Chem 274, 4722-4734 (1999)
44. Gasdaska P Y, M. M. Berggren, M. J. Berry & G. Powis: Cloning, sequencing and functional expression of a novel human thioredoxin reductase. FEBS Lett 442, 105-111 (1999)
45. Conrad M, C. Jakupoglu, S. G. Moreno, S. Lippl, A. Banjac, M. Schneider, H. Beck, A. K. Hatzopoulos, U. Just, F. Sinowatz, W. Schmahl, K. R. Chien, W. Wurst, G. W. Bornkamm & M. Brielmeier: Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol Cell Biol 24, 9414-9423 (2004)
46. Kim M R, H. S. Chang, B. H. Kim, S. Kim, S. H. Back, J. H. Kim, S. R. Lee & J. R. Kim: Involvements of mitochondrial thioredoxin reductase (TrxR2) in cell proliferation. Biochem Biophys Res Commun 304, 119-124 (2003)
47. Hammond C L, T. K. Lee & N. Ballatori Novel roles for glutathione in gene expression, cell death, and membrane transport of organic solutes. J Hepatol 34, 946-954 (2001)
48. Fernandez-Checa J C, C. Garcia-Ruiz, A. Colell, A. Morales, M. Mari, M. Miranda & E. Ardite: Oxidative stress: role of mitochondria and protection by glutathione. Biofactors 8, 7-11 (1998)
49. Boyd-Kimball D, R. Sultana, H. M. Abdul & D. A. Butterfield: Gamma-glutamylcysteine ethyl ester-induced upregulation of glutathione protects neurons against Abeta(1-42)-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. J Neurosci Res 79, 700-706 (2005)
50. Cardoso S M & C. R. Oliveira: Glutathione cycle impairment mediates A beta-induced cell toxicity. Free Radic Res 37, 241-250 (2003)
51. Coppola S & L. Ghibelli: GSH extrusion and and the mitochondrial pathway of apoptotic signalling. Biochem Soc Trans 28, 56-61 (2000)
52. Gladyshev V N, A. Liu, S. V. Novoselov, K. Krysan, Q. A. Sun, V. M. Kryukov, G. V. Kryukov & M. F. Lou: Identification and characterization of a new mammalian glutaredoxin (thioltransferase), Grx2. J Biol Chem 276, 30374-30380 (2001)
53. Beer S M, E. R. Taylor, S. E. Brown, C. C. Dahm, N. J. Costa, M. J. Runswick & M. P. Murphy: Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: implications for mitochondrial redox regulation and antioxidant defense. J Biol Chem 279, 47939-47951 (2004)
54. Enoksson M, A. P. Fernandes, S. Prast, C. H. Lillig, A. Holmgren & S. Orrenius: Overexpression of glutaredoxin 2 attenuates apoptosis by preventing cytochrome c release. Biochem Biophys Res Commun 327, 774-779 (2005)
55. Lillig C H, C. Berndt, O. Vergnolle, M. E. Lonn, C. Hudemann, E. Bill & A. Holmgren: Characterization of human glutaredoxin 2 as iron-sulfur protein: a possible role as redox sensor. Proc Natl Acad Sci USA 102, 8168-8173 (2005)
56. Keiner M J & M. A. Montoya: Structural organization of the human glutathione reductase gene: determination of correct cDNA sequence and identification of a mitochondrial leader sequence. Biochem Biophys Res Commun 269, 366-368 (2000)
57. Nakagawa Y: Role of mitochondrial phospholipid hydroperoxide glutathione peroxidase (PHGPx) as an antiapoptotic factor. Biol Pharm Bull 21, 956-960 (2004)
58. Knopp E A, T. L. Arndt, K. L. Eng, M. Caldwell, R. C. LeBoeuf, S. S. Deeb & K. D. O'Brien: Murine phospholipid hydroperoxide glutathione peroxidase: cDNA sequence, tissue expression, and mapping. Mamm Genome 10, 601-605 (1999)
59. Imai H & Y. Nakagawa. Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells. Free Radic Biol Med 34, 145-169 (2003)
60. Imai H, F. Hirao, T. Sakamoto, K. Sekine, Y. Mizukura, M. Saito, T. Kitamoto, M. Hayasaka, K. Hanaoka & Y. Nakagawa: Early embryonic lethality caused by targeted disruption of the mouse PHGPx gene. Biochem Biophys Res Commun 305, 278-286 (2003)
61. Sakamoto H, T. Tosaki & Y. Nakagawa: Overexpression of phospholipid hydroperoxide glutathione peroxidase modulates acetyl-CoA, l-O-alkyl-2-lyso- snglycero-3-phosphocholine acetyltransferase activity. J Biol Chem 111, 50431-50438 (2002)
62. Ran Q, H. Liang, M. Gu, W. Qi, C. A. Walter, L. J. Roberts, 2nd, B. Herman, A. Richardson & H. Van Remmen: Transgenic mice overexpressing glutathione peroxidase 4 are protected against oxidative stress-induced apoptosis. J Biol Chem 279, 55137-55146 (2004)
63. Hollander J M, K. M. Lin, B. T. Scott & W. H. Dillmann: Overexpression of PHGPx and HSP60/10 protects against ischemia/reoxygenation injury. Free Radic Biol Med 35, 742-751 (2003)
64. Schrauwen P & M. Hesselink: UCP2 and UCP3 in muscle controlling body metabolism. J Exp Biol 205, 2275-2285 (2002)
65. Pecqueur C, M. C. Alves-Guerra, C. Gelly, C. Levi-Meyrueis, E. Couplan, S. Collins, D. Ricquier, F. Bouillaud & B. Miroux: Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation. J Biol Chem 276, 8705-8712 (2001)
66. Cortez-Pinto H, H. Zhi Lin, S. Qi Yang, S. Odwin Da Costa & A. M. Diehl: Lipids up-regulate uncoupling protein 2 expression in rat hepatocytes. Gastroenterology 116, 1184-1193 (1999)
67. Rashid A, T. C. Wu, C. C. Huang, C. H. Chen, H. Z. Lin, S. Q. Yang, F. Y. Lee & A. M. Diehl: Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 29, 1131-1138 (1999)
68. Chavin K D, S. Yang, H. Z. Lin, J. Chatham, V. P. Chacko, J. B. Hoek, E. Walajtys-Rode, A. Rashid, C. H. Chen, C. C. Huang, T. C. Wu, M. D. Lane & A. M. Diehl: Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem 274, 5692-5700 (1999)
69. Li B, J. O. Holloszy & C. F. Semenkovich: Respiratory uncoupling induces delta-aminolevulinate synthase expression through a nuclear respiratory factor-1-dependent mechanism in HeLa cells. J Biol Chem 274, 17534-17540 (1999)
70. Arsenijevic D, H. Onuma, C. Pecqueur, S. Raimbault, B. S. Manning, B. Miroux, E. Couplan, M. C. Alves-Guerra, M. Goubern, R. Surwit, F. Bouillaud, D. Richard, S. Collins & D. Ricquier:Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 26, 435-439 (2000)
71. Blanc J, M. C. Alves-Guerra, B. Esposito, S. Roussel, P. Gourdy, D. Ricquier, A. Tedgui, B. Miroux & Z. Mallat: Protective role of uncoupling protein 2 in atherosclerosis. Circulation 107, 388-390 (2003)
72. Chan C B, M. C. Saleh, V. Koshkin & M. B. Wheeler :Uncoupling protein 2 and islet function Diabetes 53 Suppl 1, S136-142 (2004)
73. Teshima Y, M. Akao, S. P. Jones & E. Marban: Uncoupling protein-2 overexpression inhibits mitochondrial death pathway in cardiomyocytes. Circ Res 93, 192-200 (2003)
74. Li L X, F. Skorpen, K. Egeberg, I. H. Jorgensen & V. Grill: Uncoupling protein-2 participates in cellular defense against oxidative stress in clonal beta-cells. Biochem Biophys Res Commun 282, 273-277 (2001)
75. Horvath T L, S. Diano & C. Barnstable: Mitochondrial uncoupling protein 2 in the central nervous system: neuromodulator and neuroprotector. Biochem Pharmacol 65, 1917-1921 (2003)
76. Diano S, R. T. Matthews, P. Patrylo, L. Yang, M. F. Seal, C. J. Barnstable & T. L. Horvath: Uncoupling protein 2 prevents neuronal death including that occurring during seizures: a mechanism for preconditioning. Endocrinology 144, 5014-5021 (2003)
77. Bechmann I, S. Diano, C. H. Warden, T. Bartfai, R. Nitsch & T. L. Horvath: Brain mitochondrial uncoupling protein 2 (UCP2): a protective stress signal in neuronal injury. Biochem Pharmacol 64, 363-367 (2002)
78. Conti B, S. Sugama, J. Lucero, R. Winsky-Sommerer, S. A. Wirz, P. Maher, Z. Andrews, A. M. Barr, M. C. Morale, C. Paneda, J. Pemberton, S. Gaidarova, M. M. Behrens, F. Beal, P. P. Sanna, T. Horvath & T. Bartfai: Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6-methyl-phenyl- tetrahydropyridine toxicity. J Neurochem 93, 493-501 (2005)
79. Calabrese V, G. Scapagnini, C. Colombrita, A. Ravagna, G. Pennisi, A. M. Giuffrida Stella, F. Galli & D. A. Butterfield: Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach. Amino Acids 25, 437-444 (2003)
80. Sammut I A & J. C. Harrison: Cardiac mitochondrial complex activity is enhanced by heat shock proteins. Clin Exp Pharmacol Physiol 30, 110-115 (2003)
81. Morimoto R I, P. E. Kroeger & J. J. Cotto: The transcriptional regulation of heat shock genes: a plethora of heat shock factors and regulatory conditions. Exs 77, 139-163 (1996)
82. Voellmy R: On mechanisms that control heat shock transcription factor activity in metazoan cells. Cell Stress Chaperones 9, 122-133 (2004)
83. Mathew A, Y. Shi, C. Jolly & R. I. Morimoto: Analysis of the mammalian heat-shock response. Inducible gene expression and heat-shock factor activity. Methods Mol Biol 99, 217-255 (2000)
84. Christians E S, L. J. Yan & I. J. Benjamin: Heat shock factor 1 and heat shock proteins: critical partners in protection against acute cell injury. Crit Care Med 30, S43-50 (2002)
85. Cotto J J & R. I. Morimoto: Stress-induced activation of the heat-shock response: cell and molecular biology of heat-shock factors. Biochem Soc Symp 64, 105-118 (1999)
86. Tavaria M, T. Gabriele, I. Kola & R. L. Anderson: A hitchhiker's guide to the human Hsp70 family. Cell Stress Chaperones 1, 23-28 (1996)
87. Barrett M J, V. Alones, K. X. Wang, L. Phan & R. H. Swerdlow: Mitochondria-derived oxidative stress induces a heat shock protein response. J Neurosci Res 78, 420-429 (2004)
88. Ostermann J, A. L. Horwich, W. Neupert & F. U. Hartl: Protein folding in mitochondria requires complex formation with hsp60 and ATP hydrolysis. Nature 341, 125-130 (1989)
89. Cabiscol E, G. Belli, J. Tamarit, P. Echave, E. Herrero & J. Ros: Mitochondrial Hsp60, resistance to oxidative stress, and the labilc iron pool are closely connected in Saccharomyces cerevisiae. J Biol Chem 277, 44531-44538 (2002)
90. Wadhwa R, K. Taira & S. C. Kaul: An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where? Cell Stress Chaperones 1, 309-316 (2002)
91. Liu Y, W. Liu, X. D. Song & J. Zuo: Effect of GRP75/mthsp70/PBP74/ mortalin overexpression on intracellular ATP level, mitochondrial membrane potential and ROS accumulation following glucose deprivation in PC12 cells. Mol Cell Biochem 268, 45-51 (2005)
92. Hohfeld J & F. U. Hartl: Role of the chaperonin cofactor Hsp10 in protein folding and sorting in yeast mitochondria. J Cell Biol 126, 305-315 (1994)
93. Lin K M, B. Lin, I. Y. Lian, R. Mestril, I. E. Scheffler & W. H. Dillmann: Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation. Circulation 103, 1787-1792 (2001)
94. Liu Q, J. Krzewska, K. Liberek & E. A. Craig: Mitochondrial Hsp70 Ssc1: role in protein folding. J Biol Chem 276, 6112-6118 (2001)
95. Sichting M, D. Mokranjac, A. Azem, W. Neupert & K. Hell: Maintenance of structure and function of mitochondrial Hsp70 chaperones requires the chaperone Hep 1. Embo J 24, 1046-1056 (2005)
96. Maines M & D.Gibbs: P. E. 30 some years of heme oxygenase: from a "molecular wrecking ball" to a "mesmerizing" trigger of cellular events. Biochem Biophys Res Commun 338, 568-577 (2005)
97. Liu H, R. Colavitti, I. I. Rovira & T. Finkel: Redox-Dependent Transcriptional Regulation. Circ Res 97, 967-974 (2005)
98. Favreau L V & C. B. Pickett: The rat quinone reductase antioxidant response element. Identification of the nucleotide sequence required for basal and inducible activity and detection of antioxidant response element-binding proteins in hepatoma and non-hepatoma cell lines. J Biol Chem 270, 24468-24474 (1995)
99. Dalton T P, H. G. Shertzer & A. Puga: Regulation of gene expression by reactive oxygen. Annu Rev Pharmacol Toxicol 39, 67-101 (1999)
100. Motohashi H, T. O'Connor, F. Katsuoka, J. D. Engel & M. Yamamoto: Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors. Gene 294, 1-12 (2002)
101. Venugopal R & A. K. Jaiswal: Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductasc1 gene. Proc Nail Acad Sci USA 93, 14960-14965 (1996)
102. Kwong M, Y. W. Kan & J. Y. Chan: The CNC basic leucine zipper factor, Nrf1, is essential for cell survival in response to oxidative stress-inducing agents. Role for Nrf1 in gamma-gcs(1) and gss expression in mouse fibroblasts. J Biol Chem 274, 37491-37498 (1999)
103. Chan K & Y. W. Kan: Nrf2 is essential for protection against acute pulmonary injury in mice. Proc Natl Acad Sci USA 96, 12731-12736 (1999)
104. Ishii T, K. Itoh, S. Takahashi, H. Sato, T. Yanagawa, Y. Katoh, S. Bannai & M. Yamamoto: Transcription factor Nrf2 coordinately regulates a group of oxidative stressinducible genes in macrophages. J Biol Chem 275, 16023-16029 (2000)
105. Leung L, M. Kwong, S. Hou, C. Lee & J. Y. Chan: Deficiency of the Nrf1 and NrO transcription factors results in early embryonic lethality and severe oxidative stress. J Biol Chem 278, 48021-48029 (2003)
106. Jaiswal A K: Regulation of antioxidant response element-dependent induction of detoxifying enzyme synthesis. Methods Enzymol 378, 221-238 (2004)
107. Borrello S & B. Demple: NF kappa B-independent transcriptional induction of the human manganous Superoxide dismutase gene. Arch Biochem Biophys 348, 289-294 (1997)
108. Kiningham K K & D. K. St Clair: Overexpression of manganese superoxide dismutase selectively modulates the activity of Jun-associated transcription factors in fibrosarcoma cells. Cancer Res 51, 5265-5271 (1997)
109. Zhao Y, Y. Xue, T. D. Oberley, K. K. Kiningham, S. M. Lin, H. C. Yen, H. Majima, J. Hines & D. St Clair: Overexpression of manganese Superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res 61, 6082-6088 (2001)
110. Xu Y, K. K. Kiningham, M. N. Devalaraja, C. C. Yeh, H. Majima, E. J. Kasarskis & D. K. St Clair: An intronic NF-kappa B element is essential for induction of the human manganese Superoxide dismutase gene by tumor necrosis factor-alpha and interleukin-1beta DNA, Cell Biol 18, 709-722 (1999)
111. Kiningham K K, C. Daosukho & D. K. St Clair: IkappaBalpha (inhibitory kappaBalpha) identified as labile represser of MnSOD (manganese Superoxide dismutase) expression, Biochem J 384, 543-549 (2004)
112. Djavaheri-Mergny M, D. Javelaud, J. Wietzerbin & F. Besancon: NF-kappaB activation prevents apoptotic oxidative stress via an increase of both thioredoxin and MnSOD levels in TNFalpha-treated Ewing sarcoma cells. FEBS Lett 578, 111-115 (2004)
113. Pizzi M, I. Sarnico, F. Boroni, M. Benarese, N. Steimberg, G. Mazzoleni, G. P. Dietz, M. Bahr, H. C. Liou & P. F. Spano NF-kappaB factor c-Rel mediates neuroprotection elicited by mGluS receptor agonists against amyloid beta-peptide toxicity. Cell Death Differ 12, 761-772 (2005)
114. Yune T Y, S. M. Lee, S. J. Kim, H. K. Park, Y. J. Oh, Y. C. Kim, G. J. Markelonis & T. H. Oh: Manganese Superoxide dismutase induced by TNF-beta is regulated transcriptionally by NF-kappaB after spinal cord injury in rats. J Neurotrauma 21, 1778-1794 (2004)
115. Vina J, C. Borras, J. Gambini, J. Sastre & F. V. Pallardo: Why females live longer than males? Importance of the upregulation of longevity-associated genes by oestrogenic compounds. FEBS Lett 579, 2541-2545 (2005)
116. Brunelle J K, E. L. Bell, N. M. Quesada, K. Vercauteren, V. Tiranti, M. Zeviani, R. C. Scarpulla & N. S. Chandel: Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab 1, 409-414 (2005)
117. Wang M, J. S. Kirk, S. Venkataraman, F. E. Domann, H. J. Zhang, F. Q. Schafer, S. W. Flanagan, C. J. Weydert, D. R. Spitz, G. R. Buettner & L. W. Oberley: Manganese Superoxide dismutase suppresses hypoxic induction of hypoxia-inducible factor-1 alpha and vascular endothelial growth factor. Oncagene (2005)
118. Ohman T, G. Parish & R. M. Jackson: Hypoxic modulation of manganese Superoxide dismutase promoter activity and gene expression in lung epithelial cells. Am J Respir Cell Mol Biol 21, 119-127 (1999)
119. O'Brien M L, B. T. Spear & H. P. Glauert: Role of oxidative stress in peroxisome proliferator-mediated carcinogenesis. Crit Rev Toxicol 35, 61-88 (2005)
120. Cabrero A, J. C. Laguna & M. Vazquez: Peroxisome proliferator- activated receptors and the control of inflammation. Curr Drug Targels Inflamm Allergy 1, 243-248 (2002)
121. Kelly L J, P. P. Vicario, G. M. Thompson, M. R. Candelore, T. W. Doebber, J. Ventre, M. S. Wu, R. Meurer, M. J. Forrest, M. W. Conner, M. A. Cascieri & D. E. Moller: Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression. Endocrinology 139, 4920-4927 (1998)
122. Medvedev A V, S. K. Snedden, S. Raimbault, D. Ricquier & S. Collins: Transcriptional regulation of the mouse uncoupling protein-2 gene. Double E-box motif is required for peroxisome proliferator-activated receptor-gamma-dependent activation. J Biol Chem 2 76, 10817-10823 (2001)
123. Lin K, J. B. Dorman, A. Rodan & C. Kenyon: daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278, 1319-1322 (1997)
124. Kops G J, T. B. Dansen, P. E. Polderman, I. Saarloos, K. W. Wirtz, P. J. Coffer, T. T. Huang, J. L. Bos, R. H. Medema & B. M. Burgering: Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419, 316-321 (2002)
125. Brunet A, A. Bonni, M. J. Zigmond, M. Z. Lin, P. Juo, L. S. Hu, M. J. Anderson, K. C. Arden, J. Blenis & M. E. Greenberg: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868 (1999)
126. Nemoto S & T. Finkel: Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295, 2450-2452 (2002)
127. Hu Y, X. Wang, L. Zeng, D. Y. Cai, K. Sabapathy, S. P. Goff, E. J. Firpo & B. Li: ERK phosphorylates p66shcA on Ser36 and subsequently regulates p27kipl expression via the Akt-FOXO3a pathway: implication of p27kipl in cell response to oxidative stress. Mol Biol Cell 16, 3705-3718 (2005)
128. Wu Z, P. Puigserver, U. Andersson, C. Zhang, G. Adelmant, V. Mootha, A. Troy, S. Cinti, B. Lowell, R. C. Scarpulla & B. M. Spiegelman: Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1 Cell 98, 115-124 (1999)
129. Vega R B, J. M. Huss & D. P. Kelly: The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol 20, 1868-1876 (2000)
130. Yoon J C, P. Puigserver, G. Chen, J. Donovan, Z. Wu, J. Rhee, G. Adelmant, J. Stafford, C. R. Kahn, D. K. Granner, C. B. Newgard & B. M. Spiegelman: Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413, 131-138 (2001)
131. Knutti D & A. Kralli: PGC-1, a versatile coactivator. Trends Endocrinol Metab 12, 360-365 (2001)
132. Puigserver P: Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha. Int J Obes (Lond) 29 Suppl 1, S5-9 (2005)
133. Puigserver P, Z. Wu, C. W. Park, R. Graves, M. Wright & B. M. Spiegelman: A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-839 (1998)
134. Pilegaard H, B. Saltin & P. D. Neufer: Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle. J Physiol 546, 851-858 (2003)
135. Lehman J J, P. M. Barger, A. Kovacs, J. E. Saffitz, D. M. Medeiros & D. P. Kelly: Peroxisome proliferatoractivated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest 106, 847-856 (2000)
136. Baar K, A. R. Wende, T. E. Jones, M. Marison, L. A. Nolle, M. Chen, D. P. Kelly & J. O. Holloszy: Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivalor PGC-1. Faseb J 16, 1879-1886 (2002)
137. Puigserver P, J. Rhee, J. Lin, Z. Wu, J. C. Yoon, C. Y. Zhang, S. Krauss, V. K. Mootha, B. B. Lowell & B. M. Spiegelman: Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol Cell 8, 971-982 (2001)
138. Handschin C, J. Rhee, J. Lin, P. T. Tarr & B. M. Spiegelman: An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1 alpha expression in muscle. Proc Natl Acad Sci USA 100, 7111-7116 (2003)
139. Fan M, J. Rhee, J. St-Pierre, C. Handschin, P. Puigserver, J. Lin, S. Jaeger, H. Erdjument-Bromage, P. Tempst & B. M. Spiegelman: Suppression of mitochondrial respiration through recruitment of p 160 myb binding protein to PGC-1 alpha: modulation by p38 MAPK. Genes Dev 18, 278-289 (2004)
140. Huss J M & D. P. Kelly: Nuclear receptor signaling and cardiac energetics. Circ Res 95, 568-578 (2004)
141. St-Pierre J, J. Lin, S. Krauss, P. T. Tarr, R. Yang, C. B. Newgard & B. M. Spiegelman: Bioenergeric analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-lalpha and PGC-1beta) in muscle cells. J Biol Chem 278, 26597-26603 (2003)
142. Lin J, P. H. Wu, P. T. Tarr, K. S. Lindenberg, J. St-Pierre, C. Y. Zhang, V. K. Mootha, S. Jager, C. R. Vianna, R. M. Reznick, L. Cui, M. Manieri, M. X. Donovan, Z. Wu, M. P. Cooper, M. C. Fan, L. M. Rohas, A. M. Zavacki, S. Cinti, G. I. Shulman, B. B. Lowell, D. Krainc & B. M. Spiegelman: Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-lalpha null mice. Cell 119, 121-135 (2004)
143. Leone T C, J. J. Lehman, B. N. Finck, P. J. Schaeffer, A. R. Wende, S. Boudina, M. Courtois, D. F. Wozniak, N. Sambandam, C. Bernal-Mizrachi, Z. Chen, J. O. Holloszy, D. M. Medeiros, R. E. Schmidt, J. E. Saffitz, E. D. Abel, C. F. Semenkovich & D. P. Kelly: PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis PLoS. Biol 3, e101 (2005)
144. Valle I, A. Alvarez-Barrientos, E. Arza, S. Lamas & M. Monsalve: PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovasc Res 66, 562-573 (2005)
145. Moncada S & E. A. Higgs: Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Invest 21, 361-374 (1991)
146. Bruckdorfer R: The basics about nitric oxide. Mol Aspects Med 26, 3-31 (2005)
147. Nisoli E, E. Clementi, C. Paolucci, V. Cozzi, C. Tonello, C. Sciorati, R. Bracale, A. Valerio, M. Francolini, S. Moncada & M. O. Carruba: Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 299, 896-899 (2003)
148. Nisoli E, S. Falcone, C. Tonello, V. Cozzi, L. Palomba, M. Fiorani, A. Pisconti, S. Brunelli, A. Cardile, M. Francolini, O. Cantoni, M. O. Carruba, S. Moncada & E. Clementi: Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc Natl Acad Sci USA 101, 16507-16512 (2004)
149. Giulivi C, J.J. Poderoso & A. Boveris: Production of nitric oxide by mitochondria. J Biol Chem 273:11038-11043. (1998)
150. Lacza Z, E. Pankotai, A. Csordas, D. Gero, L. Kiss, E. M. Horvath, M. Kollai, D. W. Busija & C. Szabo: Mitochondrial NO and reactive nitrogen species production: Does mtNOS exist? Nitric Oxide (2005)
151. Cleeter M W, J. M. Cooper, V. M. Darley-Usmar, S. Moncada & A. H. Schapira: Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 345, 50-54 (1994)
152. Boveris A, L. E. Costa, J. J. Poderoso, M. C. Carreras & E. Cadenas: Regulation of mitochondrial respiration by oxygen and nitric oxide. Ann N Y Acad Sci 899, 121-135 (2000)
153. Brown G C: Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim Biophys Acta 1504, 46-57 (2001)
154. Cooper C E: Competitive, reversible, physiological? Inhibition of
155. Moncada S & J. D. Erusalimsky: Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat Rev Mol Cell Biol 3, 214-220 (2002)
156. Brown G C & C. E. Cooper: Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett 356, 295-298 (1994)
157. Shiva S, J. Y. Oh, A. L. Landar, E. Ulasova, A. Venkatraman, S. M. Bailey & V. M. Darley-Usmar: Nitroxia: the pathological consequence of dysfunction in the nitric oxide-cytochrome c oxidase signaling pathway. Free Radic Biol Med W, 297-306 (2005)
158. Brown G C: Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett 369, 136-139 (1995)
159. Riobo N A, E. Clementi, M. Melani, A. Boveris, E. Cadenas, S. Moncada & J. J. Poderoso: Nitric oxide inhibits mitochondrial NADH:ubiquinone reductase activity through peroxynitrite formation. Biochem J 359, 139-145 (2001)
160. Lauer N, T. Suvorava, U. Ruther, R. Jacob, W. Meyer, D. G. Harrison & G. Kojda: Critical involvement of hydrogen peroxide in exercise-induced up-regulation of endothelial NO synthase. Cardiovasc Res 65, 254-262 (2005)
161. Kojda G & R. Hambrecht: Molecular mechanisms of vascular adaptations to exercise. Physical activity as an effective antioxidant therapy? Cardiovasc Res 67(2), 187-197 (2005)
162. Smith R J, J. Agata, C. Xia, L. Chao & J. Chao: Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction. Life Sci 76(21), 2457-2471 (2005)
163. Coyle J T & P. Puttfarcken: Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-695 (1993)
164. Sayre L M, M. A. Smith & G. Perry: Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr Med Chem 8, 721-738 (2001)
165. Olanow C W & W. G. Tatton: Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22, 123-144 (1999)
166. Schapira A H: Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia. Biochim Biophys Acta 1410, 159-170 (1999)
167. Beal M F: Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann N Y Acad Sci 991, 120-131 (2003)
168. Przedborski S., K. Tieu, C. Perier and M. Vila MPTP as a mitochondrial neurotoxic model of Parkinson's disease. J Bioenerg Biomembr 36, 375-379 (2004)
169. Uversky V N: Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration. Cell Tissue Res 318, 225-241 (2004)
170. Berman S B & T. G. Hastings: Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J Neurochem 73, 1127-1137 (1999)
171. Ischiropoulos H& J. S. Beckman: Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest 111, 163-169 (2003)
172. Tretter L, I. Sipos & V. Adam-Vizi: Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson's disease. Neurochem Res 29, 569-577 (2004)
173. The Huntington's Disease Collaborative Research Group:A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72, 971-983 (1993)
174. MacDonald M E & J. F. Gusella: Huntington's disease: translating a CAG repeat into a pathogenic mechanism. Curr Opin Neurobiol 6, 638-643 (1996)
175. Feigin A, K. L. Leenders, J. R. Moeller, J. Missimer, G. Kuenig, P. Spetsieris, A. Antonini & D. Eidelberg: Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study. J Nucl Med 42, 1591-1595 (2001)
176. Panov A V, C. A. Gutekunst, B. R. Leavitt, M. R. Hayden, J. R. Burke, W. J. Strittmatter & J. T. Greenamyre: Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat Neurosci 5, 731-736 (2002)
177. Beal M F, E. Brouillet, B. Jenkins, R. Henshaw, B. Rosen & B. T. Hyman: Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J Neurochem 61, 1147-1150 (1993)
178. Beal M F, E. Brouillet, B. G. Jenkins, R. J. Ferrante, N. W. Kowall, J. M. Miller, E. Storey, R. Srivastava, B. R. Rosen & B. T. Hyman: Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13, 4181-4192 (1993)
179. Brouillet E, P. Hantraye, R. J. Ferrante, R. Dolan, A. Leroy-Willig, N. W. Kowall & M. F. Beal Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc Natl Acad Sci U S A 92, 7105-7109 (1995)
180. Brouillet E, F. Conde, M. F. Beal & P. Hantraye Replicating Huntington's disease phenotype in experimental animals. Prog Neurobiol 59, 427-468 (1999)
181. Milakovic T & G. V. Johnson: Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin. J Biol Chem 280, 30773-30782 (2005)
182. Kuhl D E, C. H. Markham, E. J. Metter, W. H. Riege, M. E. Phelps & J. C. Mazziotta: Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease. Res Publ Assoc Res Nerv Ment Dis 63, 199-209 (1985)
183. Tanzi R E & L. Bertram: Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120, 545-555 (2005)
184. Chagnon P, C. Betard, Y. Robitaille, A. Cholette & D. Gauvreau: Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases. Neuroreport 6, 711-715 (1995)
185. Takeda A, M. A. Smith, J. Avila, A. Nunomura, S. L. Siedlak, X. Zhu, G. Perry & L. M. Sayre: In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification. J Neurochem 75, 1234-1241 (2000)
186. Premkumar D R, M. A. Smith, P. L. Richey, R. B. Petersen, R. Castellani, R. K. Kutty, B. Wiggert, G. Perry & R. N. Kalaria: Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease. J Neurochem 65, 1399-1402 (1995)
187. Schipper H M: Heme oxygenase-1: role in brain aging and neurodegeneration. Exp Gerontol 35, 821-830 (2000)
188. Castellani R J, K. Honda, X. Zhu, A. D. Cash, A. Nunomura, G. Perry & M. A. Smith: Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease. Ageing Res Rev 3, 319-326 (2004)
189. Maynard C J, A. I. Bush, C. L. Masters, R. Cappai & Q. X. Li: Metals and amyloid-beta in Alzheimer's disease. Int J Exp Pathol 86, 147-159 (2005)
190. Hensley K, N. Hall, R. Subramaniam, P. Cole, M. Harris, M. Aksenov, M. Aksenova, S. P. Gabbita, J. F. Wu, J. M. Carney & et al.: Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem 65, 2146-2156 (1995)
191. Markesbery W R & M. A. Lovell Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging 19, 33-36 (1998)
192. Lovell M A, C. Xie & W. R. Markesbery: Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging 22, 187-194 (2001)
193. Lauderback C M, J. M. Hackett, F. F. Huang, J. N. Keller, L. I. Szweda, W. R. Markesbery & D. A. Butterfield: The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abetal-42. J Neurochem 78, 413-416 (2001)
194. Lin H, R. Bhatia & R. Lal: Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology. FASEB J 15, 2433-2444 (2001)
195. Dewji N N & C. Do: Heat shock factor-1 mediates the transcriptional activation of Alzheimer's beta-amyloid precursor protein gene in response to stress. Brain Res Mol Brain Res 35, 325-328 (1996)
196. Ciallella J R, V. V. Rangnekar & J. P. McGillis: Heat shock alters Alzheimer's beta amyloid precursor protein expression in human endothelial cells. J Neurosci Res 37, 769-776 (1994)
197. Cisse S, G. Perry, G. Lacoste-Royal, T. Cabana & D. Gauvreau: Immunochemical identification of ubiquitin and heat-shock proteins in corpora amylacea from normal aged and Alzheimer's disease brains. Acta Neuropathol (Berl) 85, 233-240 (1993)
198. Perez N, J. Sugar, S. Charya, G. Johnson, C. Merril, L. Bierer, D. Perl, V. Haroutunian & W. Wallace: Increased synthesis and accumulation of heat shock 70 proteins in Alzheimer's disease. Brain Res Mol Brain Res 11, 249-254 (1991)
199. Hamos J E, B. Oblas, D. Pulaski-Salo, W. J. Welch, D. G. Bole & D. A. Drachman: Expression of heat shock proteins in Alzheimer's disease. Neurology 41, 345-350 (1991)
200. Aliev G, M. A. Smith, J. C. de la Torre & G. Perry: Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease. Mitochondrion 4, 649-663 (2004)
201. Delgado-Escueta A V, W. A. Wilson, R. W. Olsen & R. J. Porter: New waves of research in the epilepsies: crossing into the third millennium. Adv Neurol 79, 3-58 (1999)
202. Li L M, F. Cendes, F. Andermann, C. Watson, D. R. Fish, M. J. Cook, F. Dubeau, J. S. Duncan, S. D. Shorvon, S. F. Berkovic, S. Free, A. Olivier, W. Harkness & D. L. Arnold: Surgical outcome in patients with epilepsy and dual pathology. Brain 122 ( Pt 5), 799-805 (1999)
203. Meldrum B S: Metabolic factors during prolonged seizures and their relation to nerve cell death. Adv Neurol 34, 261-275 (1983)
204. Theodore W H: Cerebral blood flow and glucose metabolism in human epilepsy. Adv Neurol 79, 873-881 (1999)
205. Greene A E, M. T. Todorova & T. N. Seyfried: Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies. J Neurochem 86, 529-537 (2003)
206. Shoffner J M, M. T. Lott, A. M. Lezza, P. Seibel, S. W. Ballinger & D. C. Wallace: Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 61, 931-937 (1990)
207. Bruce A J & M. Baudry: Oxygen free radicals in rat limbic structures after kainate-induced seizures. Free Radic Biol Med 18, 993-1002 (1995)
208. Lan J, D. C. Henshall, R. P. Simon & J. Chen: Formation of the base modification 8-hydroxyl-2′-deoxyguanosine and DNA fragmentation following seizures induced by systemic kainic acid in the rat. J Neurochem 74, 302-309 (2000)
209. Liang L P, Y. S. Ho & M. Patel: Mitochondrial superoxide production in kainate-induced hippocampal damage. Neuroscience 101, 563-570 (2000)
210. Melov S, P. Coskun, M. Patel, R. Tuinstra, B. Cottrell, A. S. Jun, T. H. Zastawny, M. Dizdaroglu, S. I. Goodman, T. T. Huang, H. Miziorko, C. J. Epstein & D. C. Wallace: Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Nail Acad Sci USA 96, 846-851 (1999)
211. Liang L P & M. Patel: Iron-sulfur enzyme mediated mitochondrial superoxide toxicity in experimental Parkinson's disease. J Neurochem 90, 1076-1084 (2004)
212. Cock H R, X. Tong, I. P. Hargreaves, S. J. Heales, J. B. Clark, P. N. Patsalos, M. Thom, M. Groves, A. H. Schapira, S. D. Shorvon & M. C. Walker :Mitochondrial dysfunction associated with neuronal death following status epilepticus in rat. Epilepsy Res 48, 157-168 (2002)
213. Peterson S L, D. Morrow, S. Liu & K. J. Liu: Hydroethidine detection of superoxide production during the lithium-pilocarpine model of status epilepticus. Epilepsy Res 49, 226-238 (2002)
214. Sullivan P G, C. Dube, K. Dorenbos, O. Steward & T. Z. Baram: Mitochondrial uncoupling protein-2 protects the immature brain from excitotoxic neuronal death. Ann Neurol 53, 711-717 (2003)
215. Henshall D C, T. Araki, C. K. Schindler, J. Q. Lan, K. L. Tiekoter, W. Taki & R. P. Simon: Activation of Bcl-2-associated death protein and counter-response of Akt within cell populations during seizure-induced neuronal death. J Neurosci 22, 8458-8465 (2002)
216. Henshall D C, D. P. Bonislawski, S. L. Skradski, T. Araki, J. Q. Lan, C. K. Schindler, R. Meller & R. P. Simon: Formation of the Apaf-1/cytochrome c complex precedes activation of caspase-9 during seizure-induced neuronal death. Cell Death Differ 8, 1169-1181 (2001)
217. Calabrese V, R. Lodi, C. Tonon, V. D'Agata, M. Sapienza, G. Scapagnini, A. Mangiameli, G. Pennisi, A. M. Stella & D. A. Butterfield Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J Neurol Sci 233, 145-162 (2005)
218. Durr A, M. Cossee, Y. Agid, V. Campuzano, C. Mignard, C. Penet, J. L. Mandel, A. Brice & M. Koenig: Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med 335, 1169-1175 (1996)
219. Campuzano V, L. Montermini, M. D. Molto, L. Pianese, M. Cossee, F. Cavalcanti, E. Monros, F. Rodius, F. Duclos, A. Monticelli, F. Zara, J. Canizares, H. Koutnikova, S. I. Bidichandani, C. Gellera, A. Brice, P. Trouillas, G. De Michele, A. Filla, R. De Frutos, F. Palau, P. I. Patel, S. Di Donato, J. L. Mandel, S. Cocozza, M. Koenig & M. Pandolfo: Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271, 1423-1427 (1996)
220. Campuzano V, L. Montermini, Y. Lutz, L. Cova, C. Hindelang, S. Jiralerspong, Y. Trottier, S. J. Kish, B. Faucheux, P. Trouillas, F. J. Authier, A. Durr, J. L. Mandel, A. Vescovi, M. Pandolfo & M. Koenig: Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet 6, 1771-1780 (1997)
221. Babcock M, D. de Silva, R. Oaks, S. Davis-Kaplan, S. Jiralerspong, L. Montermini, M. Pandolfo & J. Kaplan: Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 276, 1709-1712 (1997)
222. Koutnikova H, V. Campuzano, F. Foury, P. Dolle, O. Cazzalini & M. Koenig: Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat Genet 16, 345-351 (1997)
223. Bradley J L, J. C. Blake, S. Chamberlain, P. K. Thomas, J. M. Cooper & A. H. Schapira: Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. Hum Mol Genet 9, 275-282 (2000)
224. Puccio H & M. Koenig: Recent advances in the molecular pathogenesis of Friedreich ataxia. Hum Mol Genet 9, 887-892 (2000)
225. Simon D, H. Seznec, A. Gansmuller, N. Carelle, P. Weber, D. Metzger, P. Rustin, M. Koenig & H. Puccio: Friedreich ataxia mouse models with progressive cerebellar and sensory ataxia reveal autophagic neurodegeneration in dorsal root ganglia. J Neurosci 24, 1987-1995 (2004)
226. Cavadini P, H. A. O'Neill, O. Benada & G. Isaya: Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia. Hum Mol Genet 11, 217-227 (2002)
227. Yoon T & J. A. Cowan: Iron-sulfur cluster biosynthesis. Characterization of frataxin as an iron donor for assembly of [2Fe-2S] clusters in ISU-type proteins. J Am Chem Soc 125, 6078-6084 (2003)
228. Shoichet S A, A. T. Baumer, D. Stamenkovic, H. Sauer, A. F. Pfeiffer, C. R. Kahn, D. Muller-Wieland, C. Richter & M. Ristow: Frataxin promotes antioxidant defense in a thiol-dependent manner resulting in diminished malignant transformation in vitro. Hum Mol Genet 11, 815-821 (2002)
229. Oberley L W: Mechanism of the tumor suppressive effect of MnSOD overexpression. Biomed Pharmacother 59, 143-148 (2005)
230. Cerutti P A: Prooxidant states and tumor promotion. Science 227, 375-381 (1985)
231. St Clair D K, X. S. Wan, T. D. Oberley, K.. E. Muse & W. H. St Clair: Suppression of radiation-induced neoplastic transformation by overexpression of mitochondrial superoxide dismutase. Mol Carcinog 6, 238-242 (1992)
232. Zhong W, L. W. Oberley, T. D. Oberley & D. K. St Clair: Suppression of the malignant phenotype of human glioma cells by overexpression of manganese superoxide dismutase. Oncogene 14, 481-490 (1997)
233. Van Remmen H, Y. Ikeno, M. Hamilton, M. Pahlavani, N. Wolf, S. R. Thorpe, N. L. Alderson, J. W. Baynes, C. J. Epstein, T. T. Huang, J. Nelson, R. Strong & A. Richardson: Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics 16, 29-37 (2003)
234. Bolt H M, H. Foth, J. G. Hengstler & G. H. Degen: Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective. Toxicol Lett 151, 29-41 (2004)
235. Trosko J E & B. L. Upham: The emperor wears no clothes in the field of carcinogen risk assessment: ignored concepts in cancer risk assessment. Mutagenesis 20, 81-92 (2005)
236. Dobrovolskaia M A & S. V. Kozlov: Inflammation and cancer: when NF-kappaB amalgamates the perilous partnership. Curr Cancer Drug Targets 5, 325-344 (2005)
237. Bustamante J, L. Nutt, S. Orrenius & V. Gogvadze: Arsenic stimulates release of cytochrome c from isolated mitochondria via induction of mitochondrial permeability transition. Toxicol Appl Pharmacol 207, 110-116 (2005)
238. Liu S X, M. M. Davidson, X. Tang, W. F. Walker, M. Athar, V. Ivanov & T. K. Hei: Mitochondrial damage mediates genotoxicity of arsenic in mammalian cells. Cancer Res 65, 3236-3242 (2005)
239. Ko C B, S. J. Kim, C. Park, B. R. Kim, C. H. Shin, S. Choi, S. Y. Chung, J. H. Noh, J. H. Jeun, N. S. Kim & R. Park: Benzo(a)pyrene-induced apoptotic death of mouse hepatoma Hepa1c1c7 cells via activation of intrinsic caspase cascade and mitochondrial dysfunction. Toxicology 199, 35-46 (2004)
240. Bartsch H: Studies on biomarkers in cancer etiology and prevention: a summary and challenge of 20 years of interdisciplinary research. Mutat Res 462, 255-279 (2000)
241. Kang D & N. Hamasaki: Alterations of mitochondrial DNA in common diseases and disease states: aging, neurodegeneration, heart failure, diabetes, and cancer. Curr Med Chem 12, 429-441 (2005)
242. Copeland W C, J. T. Wachsman, F. M. Johnson & J. S. Penta: Mitochondrial DNA alterations in cancer. Cancer Invest 20, 557-569 (2002)
243. Modica-Napolitano J S & K. K. Singh: Mitochondrial dysfunction in cancer. Mitochondrion 4, 755-762 (2004)
244. Dias N & C. Bailly: Drugs targeting mitochondrial functions to control tumor cell growth. Biochem Pharmacol 70, 1-12 (2005)
245. Renschler M F: The emerging role of reactive oxygen species in cancer therapy. Eur J Cancer 40, 1934-1940 (2004)
246. Beckman K B & B. N. Ames: Mitochondrial aging: open questions. Ann N Y Acad Sci 854, 118-127 (1998)
247. Kirkwood T B & S. N. Austad: Why do we age? Nature 408, 233-238 (2000)
248. Balaban R S, S. Nemoto & T. Finkel: Mitochondria, oxidants, and aging. Cell 120, 483-495 (2005)
249. Cejkova J, M. Vejrazka, J. Platenik & S. Stipek: Age-related changes in superoxide dismutase, glutathione peroxidase, catalase and xanthine oxidoreductase/xanthine oxidase activities in the rabbit cornea. Exp Gerontol 39, 1537-1543 (2004)
250. Genova M L, M. M. Pich, A. Bernacchia, C. Bianchi, A. Biondi, C. Bovina, A. I. Falasca, G. Formiggini, G. P. Castelli & G. Lenaz: The mitochondrial production of reactive oxygen species in relation to aging and pathology. Ann N Y Acad Sci 1011, 86-100 (2004)
251. Sastre J, F.V. Pallardo & J.Vina The role of mitochondrial oxidative stress in aging. Free Radic Biol Med 35, 1-8 (2003)
252. Terman A, H. Dalen, J. W. Eaton, J. Neuzil & U. T. Brunk: Aging of cardiac myocytes in culture: oxidative stress, lipofuscin accumulation, and mitochondrial turnover. Ann N Y Acad Sci 1019, 70-77 (2004)
253. Stadtman E R & R. L. Levine: Protein oxidation. Ann N Y Acad Sci 899, 191-208 (2000)
254. Mecocci P, M. F. Beal, R. Cecchetti, M. C. Polidori, A. Cherubini, F. Chionne, L. Avellini, G. Romano & U. Senin: Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain. Mol Chem Neuropathol 31, 53-64 (1997)
255. Mecocci P, U. MacGarvey & M. F. Beal: Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neural 36, 747-751 (1994)
256. Paradies G, F. M. Ruggiero, G. Petrosillo & E. Quagliariello: Age-dependent decline in the cytochrome c oxidase activity in rat heart mitochondria: role of cardiolipin. FEBS Lett 406, 136-138 (1997)
257. Hagen T M, D. L. Yowe, J. C. Bartholomew, C. M. Wehr, K. L. Do, J. Y. Park & B. N. Ames: Mitochondrial decay in hepatocytes from old rats: membrane potential declines, heterogeneity and oxidants increase. Proc Natl Acad Sci U S A 94, 3064-3069 (1997)
258. Muller-Hocker J: Cytochrome c oxidase deficient fibres in the limb muscle and diaphragm of man without muscular disease: an age-related alteration. J Neurol Sci 100, 14-21 (1990)
259. Toescu E C, N. Myronova & A. Verkhratsky: Age-related structural and functional changes of brain mitochondria. Cell Calcium 28, 329-338 (2000)
260. Coleman R, A. Weiss, S. Finkelbrand & M. Silbermann: Age and exercise-related changes in myocardial mitochondria in mice. Acta Histochem 83, 81-90 (1988)
261. Lowell B B & G. I. Shulman: Mitochondrial dysfunction and type 2 diabetes. Science 307, 384-387 (2005)
262. Green K, M. D. Brand & M. P. Murphy: Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes 53 Suppl 1, S110-118 (2004)
263. Dandona P, A. Aljada, A. Chaudhuri, P. Mohanty & R. Garg: Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111, 1448-1454 (2005)
264. Brownlee M: A radical explanation for glucose-induced beta cell dysfunction. J Clin Invest 112, 1788-1790 (2003)
265. Glass C K & J. L. Witztum: Atherosclerosis. the road ahead. Cell 104, 503-516 (2001)
266. Loscalzo J: Oxidant stress: a key determinant of atherothrombosis. Biochem Soc Trans 31, 1059-1061 (2003)
267. Nishikawa T, D. Edelstein, X. L. Du, S. Yamagishi, T. Matsumura, Y. Kaneda, M. A. Yorek, D. Beebe, P. J. Oates, H. P. Hammes, I. Giardino & M. Brownlee: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404, 787-790 (2000)
268. Jassem W & N. D. Heaton: The role of mitochondria in ischemia/reperfusion injury in organ transplantation. Kidney Int 66, 514-517 (2004)
269. Honda H M, P. Korge & J. N. Weiss Mitochondria and ischemia/reperfusion injury. Ann N Y Acad Sci 1047, 248-258 (2005)